Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wang

Showing results (421-430 of 603) with videos related to

Pageof 61
Sort By:
Journal of Neuro-Oncology|May 31, 2023
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosisDaniel Moore-Palhares, Hanbo Chen, Julia Keith, et al.
British Journal of Haematology|January 19, 2011
Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myelomaSally A Hunsucker, Valeria Magarotto, Deborah J Kuhn, et al.
Cell Death & Disease|November 3, 2023
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteinsYijing Li, Heng-Huan Lee, Vivian Changying Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2026
Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase InhibitorToby A Eyre, Yuqin Song, Olivier Hermine, et al.
Blood Advances|July 11, 2019
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphomaMatthew S Ning, Chelsea C Pinnix, Bhavana V Chapman, et al.
Journal of the National Cancer Institute|September 13, 2014
Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cellsWen Gao, Michael Wang, Li Wang, et al.
Frontiers in Medicine|April 1, 2026
Acyl-CoA synthetase long-chain family member 4-A novel prognostic marker in cutaneous melanomaSoumya Paria, Rebecca Lapides, Babak Saravi, et al.
Blood Advances|April 12, 2024
Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHLChijioke Nze, Clark R Andersen, Amy A Ayers, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2017
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOPPaolo Strati, Nathan Fowler, Sergio Pina-Oviedo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 2010
Effect of long-term storage in TRIzol on microarray-based gene expression profilingWencai Ma, Michael Wang, Zhi-Qiang Wang, et al.
Pageof 61

Showing results (421-430 of 603) with videos related to

Sort By:
Pageof 61
Journal of Neuro-Oncology|May 31, 2023
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosisDaniel Moore-Palhares, Hanbo Chen, Julia Keith, et al.
British Journal of Haematology|January 19, 2011
Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myelomaSally A Hunsucker, Valeria Magarotto, Deborah J Kuhn, et al.
Cell Death & Disease|November 3, 2023
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteinsYijing Li, Heng-Huan Lee, Vivian Changying Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2026
Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase InhibitorToby A Eyre, Yuqin Song, Olivier Hermine, et al.
Blood Advances|July 11, 2019
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphomaMatthew S Ning, Chelsea C Pinnix, Bhavana V Chapman, et al.
Journal of the National Cancer Institute|September 13, 2014
Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cellsWen Gao, Michael Wang, Li Wang, et al.
Frontiers in Medicine|April 1, 2026
Acyl-CoA synthetase long-chain family member 4-A novel prognostic marker in cutaneous melanomaSoumya Paria, Rebecca Lapides, Babak Saravi, et al.
Blood Advances|April 12, 2024
Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHLChijioke Nze, Clark R Andersen, Amy A Ayers, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2017
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOPPaolo Strati, Nathan Fowler, Sergio Pina-Oviedo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 2010
Effect of long-term storage in TRIzol on microarray-based gene expression profilingWencai Ma, Michael Wang, Zhi-Qiang Wang, et al.
Pageof 61